MedPath

DOF INC.

🇯🇵Japan
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction

Recruiting
Conditions
Breast Reconstruction
Breast Cancer Female
Interventions
Other: Acellular Dermal Matrix(ADM)
First Posted Date
2024-08-15
Last Posted Date
2024-08-15
Lead Sponsor
DOF Inc.
Target Recruit Count
120
Registration Number
NCT06555614
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Evaluation of the Clinical Effectiveness and Safety of Acellular Dermal Matrix(SC DERM® Recon) in Breast Reconstruction

Recruiting
Conditions
Breast Cancer Female
Breast Reconstruction
Interventions
Biological: Transplant acellular dermal matrix(ADM)
First Posted Date
2024-08-15
Last Posted Date
2024-08-15
Lead Sponsor
DOF Inc.
Target Recruit Count
120
Registration Number
NCT06555692
Locations
🇰🇷

Soon Chun Hyang University Hospital, Seoul, Korea, Republic of

Evaluation of ADM(SC Derm® Recon) in Breast Reconstruction

Recruiting
Conditions
Breast Cancer Female
Interventions
Other: No intervention conducts.
First Posted Date
2024-08-14
Last Posted Date
2024-08-14
Lead Sponsor
DOF Inc.
Target Recruit Count
100
Registration Number
NCT06553859
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath